Sunday, November 1, 2026

As Hunger Grows, North Korea Tells Citizens to Worship Kim More

Kim Jong-un is enforcing policies to strengthen residents' ideology amid economic crisis and curb pro-South tendencies in North Korea.

North Korean ‘Tiger Bone Liquor’ Still Sold on Chinese Websites Despite Global Outrage

North Korean tiger bone arthritis liquor and illegal hangover remedies are still prevalent in Chinese online shopping malls.

10 Years Later: Kim Yoo Jung and Park Bo Gum Reunite in Hanbok for “Moonlight Drawn by Clouds” Special

Actors Kim Yoo-jung, Park Bo-gum, Jin Young, Chae Soo-bin, and Kwak Dong-yeon reunite in traditional hanbok for a memorable photo.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

‘Dream Weight-Loss Drug’ Wegovy May Also Protect Brain Health by Reducing Risk of Adult-Onset Seizures

Semaglutide may reduce adult-onset seizure risk by 56%, suggesting a link between metabolic treatment and brain health.

Exclusive: GC Biopharma Seeks First Phase 2 Trial for Homegrown mRNA Vaccine This Week

GC Biopharma advances to Phase 2 of South Korea's mRNA vaccine program, aiming for late-stage trials after Phase 1 completion.

Patients Travel Overseas for Cell Therapies—South Korea Moves to Lower Barriers to Treatment

South Korean patients seek stem cell therapies abroad due to limited options at home, despite high costs and uncertain efficacy.

Kolon Group’s Biotech Bet Faces Uncertainty as October Trial Readout Becomes Critical

Kolon TissueGene's TG-C osteoarthritis treatment failed its first U.S. Phase 3 trial, raising doubts about the biotech's future.

Revolutionary SperoQure: How JNPMEDI is Transforming Osteoarthritis Treatment in 2026

JNPMEDI will support clinical trials for speroQure, a novel cell therapy for osteoarthritis, ensuring a smooth and effective process.

Unlocking the Brain’s Secrets: New Discovery of CSF Drainage Holes Could Revolutionize Alzheimer’s Treatment

A South Korean team discovered openings in the arachnoid membrane that allow cerebrospinal fluid to drain, crucial for brain health.

How ACM Treatment Reduces Suicide Risk in Severe Depression: A 6-Month Study

A study shows intensive management by mental health professionals can significantly reduce suicide risk in severely depressed patients.

Foreign Health Insurance Enrollment Surges 28%: What This Means for Asia’s Healthcare Landscape

Foreign health insurance in the U.S. surged 28% to 1.68 million subscribers, showing a surplus of 2.8 trillion KRW over three years.

Novo Nordisk vs Eli Lilly: Is Weight Loss Advertising Misleading?

Novo Nordisk sues Eli Lilly for misleading ads on obesity drugs, claiming false comparisons and seeking corrective action in court.

Hugel Launches Letybo in India: What This Means for the Aesthetic Market in 2026

Hugel enters the Indian market with its botulinum toxin product Letybo, targeting a 9% share in the aesthetic sector this year.

Lunit Joins Global AI Consortium for Next-Gen Drug Development: What This Means for Precision Medicine

Lunit joins an AI consortium to enhance drug development through AI-driven pathology and biomarker analysis, collaborating with global firms.

Celltrion Group’s 2 Trillion KRW Investment: What It Means for Global Bio Manufacturing by 2032

Celltrion Group plans a 2 trillion KRW investment to enhance production capacity and establish a leading position in global biotech.

Celltrion Expands PFS Production Capacity to 70 Million: What This Means for the Global Market

Celltrion Pharmaceutical plans to invest 2 trillion KRW to expand its pre-filled syringe production capacity to meet global demand.

Regenerative Medicine Expanded to Four Diseases Including Knee Osteoarthritis; Medipost and CHA Biotech Seen as Potential Beneficiaries

The Korean government is easing regulations on regenerative medicine, boosting biotech, and enabling patient access to validated therapies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.